Pakistan has started production of its homemade single-dose vaccine, PakVac, for COVID-19 disease at its own plant to reduce dependence on importing vaccine from other countries.
The country will produce three million doses per month of the vaccine that was developed by its National Institute of Health (NIH) with the help of a Chinese vaccine company CanSinoBio, meeting the World Health Organisation’s (WHO) standards, reports Gulf News.
A Pakistani official said the initial capacity of this plant is 100,000 doses per day and the vaccine has passed the rigorous internal QA testing, an important step to help in the vaccine supply line.
With the production of the homemade vaccine, Pakistan’s dependence on other countries for the COVID-19 vaccine will significantly reduce, the government said on its official Twitter handle.